{"id":90601,"date":"2020-01-26T12:24:03","date_gmt":"2020-01-26T12:24:03","guid":{"rendered":"https:\/\/www.edristi.in\/?p=90601"},"modified":"2020-01-26T12:24:05","modified_gmt":"2020-01-26T12:24:05","slug":"who-approved-worlds-first-biosimilar-medicine","status":"publish","type":"post","link":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/who-approved-worlds-first-biosimilar-medicine\/","title":{"rendered":"WHO approved World\u2019s first biosimilar Medicine"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Question: World Health Organization (WHO) has approved first biosimilar medicine Trastuzumab. It will be used for the treatment of-<br> (a) Diabetes<br> (b) Breast Cancer<br> (c) TB<br> (d) Leukemia<br> Answer: (b)<br> Related facts:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>On 18 December, 2019; The World Health Organization (WHO) has approved first biosimilar medicine.<\/li><li>This medicine named as Trastuzumab, is an injection to be used for breast cancer treatment.<\/li><li>It should be noted that biosimilar medicine is derived from living sources instead of the chemicals. <\/li><li>Noticeable that about 150,000 new patients is diagnosed with breast cancer every year in India.<\/li><li>Out of these nearly a fourth of the cases are HER2-positive and eligible for treatment with CANMAb (Trastuzumab)<\/li><li>The aim is to make breast cancer treatment affordable to women globally. This approval from WHO is first of such kind.<\/li><\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>High efficacy of Trastuzumab:-<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>The Trastuzumab drug has proved high efficacy in curing early-stage breast cancer and in some cases more advanced forms of the disease.<\/li><li>Trastuzumab, made out of nonbio sources, costs about Rs 1400000 annually for the patients undergoing breast cancer treatment. <\/li><li>The high cost of the drug makes it out of reach of many women and healthcare systems in most countries <\/li><li>The biosimilar version of Trastuzumab is much cheaper than the original. <\/li><li>The drug is cheaper but equally effective biotherapeutic medicines are produced from biological sources such as cells rather than synthesized chemicals. <\/li><\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Production of Trastuzumab in India:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>In January, 2014 Bangalore-based bio-pharmaceutical company Biocon launched the world\u2019s first biosimilar (developed in an organism) Trastuzumab injection.<\/li><li>Biocon Limited is an Indian biopharmaceutical company based in Bangalore, India and founded by Kiran Mazumdar-Shaw.<\/li><li>This was the first drug developed by Biocon in partnership with US-based generic drug maker Mylan. <\/li><li>The new drug Trastuzumab sold under the brand name CANMAb by the Biocon will be used to treat HER2-positive advanced breast cancer.<\/li><li>The drug has been jointly developed out of five molecules with Mylan, since a partnership was signed in 2009.<\/li><li>Mylan will also launch CANMab under a different brand in India.<\/li><li>The injection is available in 150mg and 440mg doses at Rs 19,500 and Rs 57,500, respectively. <\/li><li>The 440mg dose costs a fourth less than competing drugs, Mazumdar-Shaw said.<\/li><\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Links:<br><a href=\"https:\/\/www.who.int\/news-room\/detail\/18-12-2019-who-prequalifies-first-biosimilar-medicine-to-increase-worldwide-access-to-life-saving-breast-cancer-treatment\">https:\/\/www.who.int\/news-room\/detail\/18-12-2019-who-prequalifies-first-biosimilar-medicine-to-increase-worldwide-access-to-life-saving-breast-cancer-treatment<br><\/a><a href=\"https:\/\/www.business-standard.com\/article\/companies\/world-s-1st-biosimilar-drug-for-breast-cancer-114011800354_1.html\">https:\/\/www.business-standard.com\/article\/companies\/world-s-1st-biosimilar-drug-for-breast-cancer-114011800354_1.html<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Question: World Health Organization (WHO) has approved first biosimilar medicine Trastuzumab. It will be used for the treatment of- (a) Diabetes (b) Breast Cancer (c) TB (d) Leukemia Answer: (b) Related facts: On 18 December, 2019; The World Health Organization (WHO) has approved first biosimilar medicine. This medicine named as Trastuzumab, is an injection to [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":90602,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1123],"tags":[3067],"class_list":["post-90601","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-snes","tag-scientific"],"_links":{"self":[{"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/posts\/90601","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/comments?post=90601"}],"version-history":[{"count":0,"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/posts\/90601\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/media\/90602"}],"wp:attachment":[{"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/media?parent=90601"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/categories?post=90601"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/tags?post=90601"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}